Annual Total Assets
$1.28 B
-$424.83 M-24.95%
31 December 2023
Summary:
Supernus Pharmaceuticals annual total assets is currently $1.28 billion, with the most recent change of -$424.83 million (-24.95%) on 31 December 2023. During the last 3 years, it has fallen by -$226.43 million (-15.05%). SUPN annual total assets is now -24.95% below its all-time high of $1.70 billion, reached on 31 December 2022.SUPN Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$1.34 B
+$26.87 M+2.04%
30 September 2024
Summary:
Supernus Pharmaceuticals quarterly total assets is currently $1.34 billion, with the most recent change of +$26.87 million (+2.04%) on 30 September 2024. Over the past year, it has increased by +$57.54 million (+4.48%). SUPN quarterly total assets is now -25.06% below its all-time high of $1.79 billion, reached on 31 March 2023.SUPN Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SUPN Total Assets Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -24.9% | +4.5% |
3 y3 years | -15.1% | -13.7% |
5 y5 years | +30.7% | +21.3% |
SUPN Total Assets High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -24.9% | at low | -25.1% | +5.1% |
5 y | 5 years | -24.9% | +30.7% | -25.1% | +21.3% |
alltime | all time | -24.9% | +2617.9% | -25.1% | +4056.7% |
Supernus Pharmaceuticals Total Assets History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $1.34 B(+2.0%) |
June 2024 | - | $1.32 B(+0.9%) |
Mar 2024 | - | $1.30 B(+2.1%) |
Dec 2023 | $1.28 B(-25.0%) | $1.28 B(-0.6%) |
Sept 2023 | - | $1.29 B(-0.6%) |
June 2023 | - | $1.29 B(-27.8%) |
Mar 2023 | - | $1.79 B(+5.2%) |
Dec 2022 | $1.70 B(+0.8%) | $1.70 B(+0.6%) |
Sept 2022 | - | $1.69 B(-0.1%) |
June 2022 | - | $1.69 B(+3.4%) |
Mar 2022 | - | $1.64 B(-2.9%) |
Dec 2021 | $1.69 B(+12.3%) | $1.69 B(+8.6%) |
Sept 2021 | - | $1.56 B(-1.1%) |
June 2021 | - | $1.57 B(+4.4%) |
Mar 2021 | - | $1.51 B(+0.2%) |
Dec 2020 | $1.50 B(+29.6%) | $1.50 B(-0.4%) |
Sept 2020 | - | $1.51 B(+1.3%) |
June 2020 | - | $1.49 B(+25.3%) |
Mar 2020 | - | $1.19 B(+2.5%) |
Dec 2019 | $1.16 B(+18.7%) | $1.16 B(+4.8%) |
Sept 2019 | - | $1.11 B(+4.1%) |
June 2019 | - | $1.06 B(+3.7%) |
Mar 2019 | - | $1.03 B(+4.9%) |
Dec 2018 | $977.81 M(+130.4%) | $977.81 M(+6.0%) |
Sept 2018 | - | $922.51 M(+8.2%) |
June 2018 | - | $852.80 M(+3.3%) |
Mar 2018 | - | $825.16 M(+94.4%) |
Dec 2017 | $424.46 M | $424.46 M(+10.1%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2017 | - | $385.48 M(+11.3%) |
June 2017 | - | $346.37 M(+7.5%) |
Mar 2017 | - | $322.26 M(+4.1%) |
Dec 2016 | $309.57 M(+64.1%) | $309.57 M(+8.6%) |
Sept 2016 | - | $285.12 M(+30.4%) |
June 2016 | - | $218.63 M(+12.4%) |
Mar 2016 | - | $194.47 M(+3.1%) |
Dec 2015 | $188.63 M(+37.9%) | $188.63 M(+13.1%) |
Sept 2015 | - | $166.77 M(+8.2%) |
June 2015 | - | $154.17 M(+10.4%) |
Mar 2015 | - | $139.64 M(+2.1%) |
Dec 2014 | $136.78 M(+23.2%) | $136.78 M(+8.3%) |
Sept 2014 | - | $126.33 M(+34.1%) |
June 2014 | - | $94.19 M(-3.4%) |
Mar 2014 | - | $97.52 M(-12.1%) |
Dec 2013 | $111.00 M(+18.1%) | $111.00 M(-10.3%) |
Sept 2013 | - | $123.77 M(-6.2%) |
June 2013 | - | $131.97 M(+66.9%) |
Mar 2013 | - | $79.06 M(-15.9%) |
Dec 2012 | $93.99 M(+74.9%) | $93.99 M(+40.3%) |
Sept 2012 | - | $67.01 M(-16.2%) |
June 2012 | - | $79.97 M(+85.1%) |
Mar 2012 | - | $43.20 M(-19.6%) |
Dec 2011 | $53.73 M(+14.3%) | $53.73 M(+66.3%) |
Sept 2011 | - | $32.30 M(-31.3%) |
Dec 2010 | $47.01 M(-41.2%) | $47.01 M(-18.2%) |
Sept 2010 | - | $57.50 M(-28.0%) |
Dec 2009 | $79.90 M(+3.6%) | $79.90 M |
Dec 2008 | $77.13 M | - |
FAQ
- What is Supernus Pharmaceuticals annual total assets?
- What is the all time high annual total assets for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals annual total assets year-on-year change?
- What is Supernus Pharmaceuticals quarterly total assets?
- What is the all time high quarterly total assets for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals quarterly total assets year-on-year change?
What is Supernus Pharmaceuticals annual total assets?
The current annual total assets of SUPN is $1.28 B
What is the all time high annual total assets for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high annual total assets is $1.70 B
What is Supernus Pharmaceuticals annual total assets year-on-year change?
Over the past year, SUPN annual total assets has changed by -$424.83 M (-24.95%)
What is Supernus Pharmaceuticals quarterly total assets?
The current quarterly total assets of SUPN is $1.34 B
What is the all time high quarterly total assets for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high quarterly total assets is $1.79 B
What is Supernus Pharmaceuticals quarterly total assets year-on-year change?
Over the past year, SUPN quarterly total assets has changed by +$57.54 M (+4.48%)